Healthcare - Biotechnology - NASDAQ - US
$ 33.215
0.651 %
$ 1.89 B
Market Cap
15.74
P/E
Price Target
Average
38.92%
Revenue Forecast
Estimate
28.07%
EBIT
Estimate
--6.09%
Net Income
Estimate
47.32%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Harmony Biosciences Holdings, Inc.
Wall Street analysts predict an average 1-year price target for HRMY of $46.1 , with forecasts ranging from a low of $28 to a high of $56 .
HRMY Lowest Price Target
Wall Street Target
28 USD
-15.70%
HRMY Average Price Target
Wall Street Target
46.1 USD
38.92%
HRMY Highest Price Target
Wall Street Target
56 USD
68.60%
REVENUE FORECAST
Revenue Forecast Chart HRMY
EBIT FORECAST
EBIT Forecast Chart HRMY
NET INCOME FORECAST
Net Income Chart HRMY